Johnson Financial Group Inc. Takes $59,000 Position in Exponent, Inc. (NASDAQ:EXPO)

Johnson Financial Group Inc. acquired a new stake in shares of Exponent, Inc. (NASDAQ:EXPO) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 640 shares of the business services provider’s stock, valued at approximately $59,000.

A number of other hedge funds have also recently modified their holdings of EXPO. Raymond James Financial Inc. bought a new stake in shares of Exponent during the 4th quarter valued at $55,131,000. Norges Bank bought a new stake in shares of Exponent during the 4th quarter valued at $52,381,000. Resona Asset Management Co. Ltd. bought a new stake in shares of Exponent during the 4th quarter valued at $38,538,000. JPMorgan Chase & Co. boosted its holdings in Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after buying an additional 245,086 shares during the period. Finally, Barclays PLC boosted its holdings in Exponent by 88.5% in the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider’s stock worth $16,209,000 after buying an additional 85,395 shares during the period. Institutional investors own 92.37% of the company’s stock.

Insider Buying and Selling

In other Exponent news, VP Richard Reiss sold 1,736 shares of the business’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. The trade was a 49.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is currently owned by insiders.

Exponent Stock Performance

Shares of Exponent stock opened at $78.20 on Tuesday. The company has a market capitalization of $3.97 billion, a P/E ratio of 36.89 and a beta of 0.84. The company has a fifty day moving average of $81.17 and a 200 day moving average of $90.50. Exponent, Inc. has a fifty-two week low of $73.83 and a fifty-two week high of $115.75.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the prior year, the company posted $0.41 earnings per share. Analysts forecast that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.